Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model.

about

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model.

Item

http://www.wikidata.org/entity/Q38826424

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Orthotopic Implantation and Pe ...... geneic Rat Mesothelioma Model.

@en

type

Item

label

Orthotopic Implantation and Pe ...... geneic Rat Mesothelioma Model.

@en

prefLabel

Orthotopic Implantation and Pe ...... geneic Rat Mesothelioma Model.

@en

P1476

Orthotopic Implantation and Pe ...... geneic Rat Mesothelioma Model.

@en

P2093

Amanda L Hudson

http://www.w3.org/2001/XMLSchema#string

Chris J Weir

http://www.w3.org/2001/XMLSchema#string

Lyndsay Peters

http://www.w3.org/2001/XMLSchema#string

Viive M Howell

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Uncertainty in the translation of preclinical experiments to clinical trials. Why do most phase III clinical trials fail?

Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice.

Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis.

Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.

Characteristics of tumors and tumor cells cultured from experimental asbestos-induced mesotheliomas in rats

What's wrong with our cancer models?

P31

scholarly article

P356

10.3791/53019

http://www.w3.org/2001/XMLSchema#string

P433

104

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282584271

http://www.w3.org/2001/XMLSchema#string

P698

26485154

http://www.w3.org/2001/XMLSchema#string

P932

4692642

http://www.w3.org/2001/XMLSchema#string